Condition | Indicated | Relationship Strength | Studies | Trials |
Extravascular Hemolysis [description not available] | 0 | 10.52 | 9 | 0 |
Hemolysis The destruction of ERYTHROCYTES by many different causal agents such as antibodies, bacteria, chemicals, temperature, and changes in tonicity. | 0 | 10.52 | 9 | 0 |
Autoimmune Disease [description not available] | 0 | 3.97 | 2 | 0 |
Autoimmune Diseases Disorders that are characterized by the production of antibodies that react with host tissues or immune effector cells that are autoreactive to endogenous peptides. | 0 | 3.97 | 2 | 0 |
Marchiafava-Micheli Syndrome [description not available] | 0 | 4.92 | 4 | 0 |
Hemoglobinuria, Paroxysmal A condition characterized by the recurrence of HEMOGLOBINURIA caused by intravascular HEMOLYSIS. In cases occurring upon cold exposure (paroxysmal cold hemoglobinuria), usually after infections, there is a circulating antibody which is also a cold hemolysin. In cases occurring during or after sleep (paroxysmal nocturnal hemoglobinuria), the clonal hematopoietic stem cells exhibit a global deficiency of cell membrane proteins. | 0 | 4.92 | 4 | 0 |
Innate Inflammatory Response [description not available] | 0 | 5.34 | 8 | 0 |
Blood Clot [description not available] | 0 | 5.02 | 2 | 1 |
Inflammation A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function. | 0 | 5.34 | 8 | 0 |
Thrombosis Formation and development of a thrombus or blood clot in the blood vessel. | 0 | 5.02 | 2 | 1 |
Coagulation Disorders, Blood [description not available] | 0 | 2.25 | 1 | 0 |
Blood Coagulation Disorders Hemorrhagic and thrombotic disorders that occur as a consequence of abnormalities in blood coagulation due to a variety of factors such as COAGULATION PROTEIN DISORDERS; BLOOD PLATELET DISORDERS; BLOOD PROTEIN DISORDERS or nutritional conditions. | 0 | 2.25 | 1 | 0 |
Postoperative Cognitive Complications COGNITIVE IMPAIRMENT or functional decline after a surgical procedure. | 0 | 2.25 | 1 | 0 |
Cholera Infantum [description not available] | 0 | 2.25 | 1 | 0 |
Anesthesia A state characterized by loss of feeling or sensation. This depression of nerve function is usually the result of pharmacologic action and is induced to allow performance of surgery or other painful procedures. | 0 | 2.25 | 1 | 0 |
Infections, Coronavirus [description not available] | 0 | 6.57 | 5 | 1 |
2019 Novel Coronavirus Disease [description not available] | 0 | 6.57 | 5 | 1 |
Auricular Fibrillation [description not available] | 0 | 3.17 | 1 | 0 |
Elevated Cholesterol [description not available] | 0 | 3.17 | 1 | 0 |
Blood Pressure, High [description not available] | 0 | 3.17 | 1 | 0 |
Atrial Fibrillation Abnormal cardiac rhythm that is characterized by rapid, uncoordinated firing of electrical impulses in the upper chambers of the heart (HEART ATRIA). In such case, blood cannot be effectively pumped into the lower chambers of the heart (HEART VENTRICLES). It is caused by abnormal impulse generation. | 0 | 3.17 | 1 | 0 |
Hypercholesterolemia A condition with abnormally high levels of CHOLESTEROL in the blood. It is defined as a cholesterol value exceeding the 95th percentile for the population. | 0 | 3.17 | 1 | 0 |
Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. | 0 | 3.17 | 1 | 0 |
Pneumonia, Viral Inflammation of the lung parenchyma that is caused by a viral infection. | 0 | 6.57 | 5 | 1 |
Coronavirus Infections Virus diseases caused by the CORONAVIRUS genus. Some specifics include transmissible enteritis of turkeys (ENTERITIS, TRANSMISSIBLE, OF TURKEYS); FELINE INFECTIOUS PERITONITIS; and transmissible gastroenteritis of swine (GASTROENTERITIS, TRANSMISSIBLE, OF SWINE). | 0 | 6.57 | 5 | 1 |
Acute Respiratory Distress Syndrome [description not available] | 0 | 4.26 | 3 | 1 |
Respiratory Distress Syndrome A syndrome characterized by progressive life-threatening RESPIRATORY INSUFFICIENCY in the absence of known LUNG DISEASES, usually following a systemic insult such as surgery or major TRAUMA. | 0 | 4.26 | 3 | 1 |
Thrombotic Microangiopathies Diseases that result in THROMBOSIS in MICROVASCULATURE. The two most prominent diseases are PURPURA, THROMBOTIC THROMBOCYTOPENIC; and HEMOLYTIC-UREMIC SYNDROME. Multiple etiological factors include VASCULAR ENDOTHELIAL CELL damage due to SHIGA TOXIN; FACTOR H deficiency; and aberrant VON WILLEBRAND FACTOR formation. | 0 | 3.98 | 2 | 0 |
Hemorrhagic Shock [description not available] | 0 | 7.21 | 1 | 0 |
Age-Related Macular Degeneration [description not available] | 0 | 3.92 | 4 | 0 |
Drusen, Retinal [description not available] | 0 | 2.78 | 3 | 0 |
Eye Diseases, Hereditary Transmission of gene defects or chromosomal aberrations/abnormalities which are expressed in extreme variation in the structure or function of the eye. These may be evident at birth, but may be manifested later with progression of the disorder. | 0 | 2.17 | 1 | 0 |
Macular Degeneration Degenerative changes in the RETINA usually of older adults which results in a loss of vision in the center of the visual field (the MACULA LUTEA) because of damage to the retina. It occurs in dry and wet forms. | 0 | 8.92 | 4 | 0 |
Cancer-Associated Pain [description not available] | 0 | 2.17 | 1 | 0 |
Bone Cancer [description not available] | 0 | 2.17 | 1 | 0 |
Allodynia [description not available] | 0 | 2.17 | 1 | 0 |
Experimental Mammary Neoplasms [description not available] | 0 | 2.17 | 1 | 0 |
Cancer Pain Pain that may be caused by or related to cellular, tissue, and systemic changes that occur during NEOPLASM growth, tissue invasion, and METASTASIS. | 0 | 2.17 | 1 | 0 |
Bone Neoplasms Tumors or cancer located in bone tissue or specific BONES. | 0 | 2.17 | 1 | 0 |
Infection, Wound [description not available] | 0 | 2.17 | 1 | 0 |
Injuries Used with anatomic headings, animals, and sports for wounds and injuries. Excludes cell damage, for which pathology is used. | 0 | 2.17 | 1 | 0 |
Wounds and Injuries Damage inflicted on the body as the direct or indirect result of an external force, with or without disruption of structural continuity. | 0 | 2.17 | 1 | 0 |
Blood Poisoning [description not available] | 0 | 2.78 | 3 | 0 |
Sepsis Systemic inflammatory response syndrome with a proven or suspected infectious etiology. When sepsis is associated with organ dysfunction distant from the site of infection, it is called severe sepsis. When sepsis is accompanied by HYPOTENSION despite adequate fluid infusion, it is called SEPTIC SHOCK. | 0 | 2.78 | 3 | 0 |
Infections, Staphylococcal [description not available] | 0 | 2.1 | 1 | 0 |
Staphylococcal Infections Infections with bacteria of the genus STAPHYLOCOCCUS. | 0 | 2.1 | 1 | 0 |
Bacteroidaceae Infections Infections with bacteria of the family BACTEROIDACEAE. | 0 | 2.1 | 1 | 0 |
Bone Loss, Osteoclastic [description not available] | 0 | 2.1 | 1 | 0 |
Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. | 0 | 2.76 | 3 | 0 |
Pericementitis [description not available] | 0 | 2.1 | 1 | 0 |
Periodontitis Inflammation and loss of connective tissues supporting or surrounding the teeth. This may involve any part of the PERIODONTIUM. Periodontitis is currently classified by disease progression (CHRONIC PERIODONTITIS; AGGRESSIVE PERIODONTITIS) instead of age of onset. (From 1999 International Workshop for a Classification of Periodontal Diseases and Conditions, American Academy of Periodontology) | 0 | 2.1 | 1 | 0 |
Central Nervous System Disease [description not available] | 0 | 3.01 | 1 | 0 |
Central Nervous System Diseases Diseases of any component of the brain (including the cerebral hemispheres, diencephalon, brain stem, and cerebellum) or the spinal cord. | 0 | 3.01 | 1 | 0 |
Extramembranous Glomerulopathy [description not available] | 0 | 3.03 | 1 | 0 |
DDD MPGNII [description not available] | 0 | 3.03 | 1 | 0 |
Glomerulonephritis, Membranoproliferative Chronic glomerulonephritis characterized histologically by proliferation of MESANGIAL CELLS, increase in the MESANGIAL EXTRACELLULAR MATRIX, and a thickening of the glomerular capillary walls. This may appear as a primary disorder or secondary to other diseases including infections and autoimmune disease SYSTEMIC LUPUS ERYTHEMATOSUS. Various subtypes are classified by their abnormal ultrastructures and immune deposits. Hypocomplementemia is a characteristic feature of all types of MPGN. | 0 | 3.03 | 1 | 0 |
Glomerulonephritis, Membranous A type of glomerulonephritis that is characterized by the accumulation of immune deposits (COMPLEMENT MEMBRANE ATTACK COMPLEX) on the outer aspect of the GLOMERULAR BASEMENT MEMBRANE. It progresses from subepithelial dense deposits, to basement membrane reaction and eventual thickening of the basement membrane. | 0 | 3.03 | 1 | 0 |
Diabetes Mellitus A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE. | 0 | 3.03 | 1 | 0 |
E coli Infections [description not available] | 0 | 2.48 | 2 | 0 |
Cirrhosis [description not available] | 0 | 2.11 | 1 | 0 |
Escherichia coli Infections Infections with bacteria of the species ESCHERICHIA COLI. | 0 | 2.48 | 2 | 0 |
Fibrosis Any pathological condition where fibrous connective tissue invades any organ, usually as a consequence of inflammation or other injury. | 0 | 2.11 | 1 | 0 |
Bacteremia The presence of viable bacteria circulating in the blood. Fever, chills, tachycardia, and tachypnea are common acute manifestations of bacteremia. The majority of cases are seen in already hospitalized patients, most of whom have underlying diseases or procedures which render their bloodstreams susceptible to invasion. | 0 | 2.11 | 1 | 0 |
Plasmodium falciparum Malaria [description not available] | 0 | 2.13 | 1 | 0 |
Anemia A reduction in the number of circulating ERYTHROCYTES or in the quantity of HEMOGLOBIN. | 0 | 7.13 | 1 | 0 |
Malaria, Falciparum Malaria caused by PLASMODIUM FALCIPARUM. This is the severest form of malaria and is associated with the highest levels of parasites in the blood. This disease is characterized by irregularly recurring febrile paroxysms that in extreme cases occur with acute cerebral, renal, or gastrointestinal manifestations. | 0 | 2.13 | 1 | 0 |
ANCA-Associated Vasculitides [description not available] | 0 | 3.06 | 1 | 0 |
Atypical Hemolytic-Uremic Syndrome [description not available] | 0 | 3.06 | 1 | 0 |
Berger Disease [description not available] | 0 | 3.06 | 1 | 0 |
Glomerulonephritis, IGA A chronic form of glomerulonephritis characterized by deposits of predominantly IMMUNOGLOBULIN A in the mesangial area (GLOMERULAR MESANGIUM). Deposits of COMPLEMENT C3 and IMMUNOGLOBULIN G are also often found. Clinical features may progress from asymptomatic HEMATURIA to END-STAGE KIDNEY DISEASE. | 0 | 3.06 | 1 | 0 |
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis Group of systemic vasculitis with a strong association with ANCA. The disorders are characterized by necrotizing inflammation of small and medium size vessels, with little or no immune-complex deposits in vessel walls. | 0 | 3.06 | 1 | 0 |
Atypical Hemolytic Uremic Syndrome An hereditary hemolytic uremic syndrome associated with variations in the gene that encodes COMPLEMENT FACTOR H, or the related proteins CFHR1 and CFHR3. Disease often progresses to CHRONIC KIDNEY FAILURE without the prodromal symptoms of ENTEROCOLITIS and DIARRHEA that characterize typical hemolytic uremic syndrome. | 0 | 3.06 | 1 | 0 |
Sensitivity and Specificity Binary classification measures to assess test results. Sensitivity or recall rate is the proportion of true positives. Specificity is the probability of correctly determining the absence of a condition. (From Last, Dictionary of Epidemiology, 2d ed) | 0 | 2.15 | 1 | 0 |
MODS [description not available] | 0 | 2.05 | 1 | 0 |
Multiple Organ Failure A progressive condition usually characterized by combined failure of several organs such as the lungs, liver, kidney, along with some clotting mechanisms, usually postinjury or postoperative. | 0 | 2.05 | 1 | 0 |
Injury, Ischemia-Reperfusion [description not available] | 0 | 3 | 1 | 0 |
Reperfusion Injury Adverse functional, metabolic, or structural changes in tissues that result from the restoration of blood flow to the tissue (REPERFUSION) following ISCHEMIA. | 0 | 3 | 1 | 0 |